Edition:
India

Zhejiang Hisun Pharmaceutical Co Ltd (600267.SS)

600267.SS on Shanghai Stock Exchange

8.36CNY
21 Jan 2019
Change (% chg)

¥-0.11 (-1.30%)
Prev Close
¥8.47
Open
¥8.50
Day's High
¥8.55
Day's Low
¥8.33
Volume
11,448,236
Avg. Vol
12,076,337
52-wk High
¥17.75
52-wk Low
¥7.71

Latest Key Developments (Source: Significant Developments)

Zhejiang Hisun Pharmaceutical Says Board Elects Jiang Guoping As Chairman
Thursday, 29 Nov 2018 

Nov 29 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS BOARD ELECTS JIANG GUOPING AS CHAIRMAN.  Full Article

Zhejiang Hisun Pharmaceutical Chairman Resigns Due To Age And Health Reasons
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>::SAYS ITS CHAIRMAN BAI HUA RESIGNS DUE TO AGE AND HEALTH REASONS.  Full Article

Zhejiang Hisun Pharmaceutical receives approval for drug clinical trial
Monday, 21 May 2018 

May 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for drug clinical trial for a kind of injection, from China Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical and unit obtain high-tech enterprise recognition and to enjoy tax preference
Thursday, 4 Jan 2018 

Jan 4(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it and unit were recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years .  Full Article

Zhejiang Hisun Pharmaceutical passes FDA approval
Tuesday, 21 Nov 2017 

Nov 21(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received approval for a kind of tablet from U.S Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical unit says product gets FDA approval
Monday, 20 Nov 2017 

Nov 20(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says co's Hangzhou-based unit's product simvastatin tablets, gets approval from U.S. Food and Drug Administration.  Full Article

Zhejiang Hisun Pharmaceutical says product gets FDA approval
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says its product, mycophenolate mofetil capsules, gets approval from U.S. Food and Drug Administration .  Full Article

Zhejiang Hisun Pharmaceutical says change of CFO
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS> ::Says it appoints Liu Yuanyan as new CFO, replacing Guan Xuhua who resigns from the position due to internal change in job role.  Full Article

Zhejiang Hisun Pharmaceutical receives TGA-GMP certificate
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:Says it received goods manufacture practice (GMP) certificate from Therapeutic Goods Administration .Certificate issued to crude drugs manufactured by the company and the valid period is until Nov. 26, 2020 .  Full Article

Zhejiang Hisun Pharmaceutical to invest 5.1 mln yuan to set up investment management JV
Wednesday, 27 Sep 2017 

Sept 27 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd <600267.SS>:* Says it will invest 5.1 million yuan to set up Zhejiang-based investment management JV, which will be engaged in operation of pharmaceutical industry innovation projects, and hold 51 percent stake in JV after transaction .  Full Article